Effects of pimobendan (UDCG 115) on renal function in healthy volunteers. 1992

P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
University Department of Medicine, General Infirmary, Leeds, UK.

A phase I, double-blind, single-dose, randomized, two-period crossover study was conducted to investigate the effects of pimobendan on renal function to assess whether renal events were a contra-indication to its administration. Results in eight healthy volunteers indicated no significant adverse events on renal plasma flow, glomerular filtration rate, or laboratory safety screens; side-effects were also found to be minimal. Further studies are indicated to assess whether, in the proposed treatment group, i.e. patients with heart failure (in whom compromised renal function is common), pimobendan similarly elicits no serious adverse renal effects.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
October 1992, Zeitschrift fur Kardiologie,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
May 1989, Zeitschrift fur Kardiologie,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
December 1989, Journal of cardiovascular pharmacology,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
December 1992, Clinical nephrology,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
September 2023, American journal of veterinary research,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
January 2013, Clinical nephrology,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
January 1988, Journal of cardiovascular pharmacology,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
April 1990, British journal of clinical pharmacology,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
September 1988, The American journal of cardiology,
P Martin, and H Tindall, and P Rice, and P Jones, and G Tregunno, and J A Davies, and C R Prentice
January 1996, Platelets,
Copied contents to your clipboard!